Does Noxafil Vial Interact with other Medications?

Severe Interactions

These medications are not usually taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.

  • MISC ANTIFUNGAL AGENTS/ASTEMIZOLE; TERFENADINE
  • STRONG CYP3A4 INHIBIT THAT PROLONG QT/PIMAVANSERIN (> 10 MG)
  • STRONG CYP3A4 INHIBITORS/MAVACAMTEN
  • STRONG CYP3A4 INHIBITORS THAT PROLONG QT/PACRITINIB
  • STR CYP3A4 INHIBITORS THAT PROLONG QT/PANOBINOSTAT (> 10 MG)
  • STRONG CYP3A4 INHIBITORS THAT PROLONG QT/LEVOKETOCONAZOLE
  • SELECTED STRONG CYP3A4 INHIBITORS/CONIVAPTAN
  • STRONG CYP3A4 INHIBITORS THAT PROLONG QT/ALFUZOSIN
  • STRONG CYP3A4 INHIBITORS/FINERENONE
  • POSACONAZOLE/CYP3A4 SUBSTRATES THAT PROLONG QT
  • STRONG CYP3A4 INHIBITORS/VOCLOSPORIN
  • STRONG CYP3A4 INHIBITORS THAT PROLONG QT/RANOLAZINE
  • STRONG AND MODERATE CYP3A4 INHIBITORS/LONAFARNIB
  • POSACONAZOLE/LEVOMETHADONE; METHADONE
  • KETOCONAZOLE; POSACONAZOLE/SLT HMG-COA REDUCTASE INHIBITORS
  • STRONG CYP3A4 INHIBITORS THAT PROLONG QT/IVABRADINE
  • STRONG CYP3A4 INHIBITORS/LUMATEPERONE (>10.5 MG)
  • STRONG CYP3A4 INHIBITORS/UBROGEPANT
  • SELECTED STRONG CYP3A4 INHIBITORS/ALPRAZOLAM; TRIAZOLAM
  • STRONG CYP3A4 INHIBITORS; ATAZANAVIR;DARUNAVIR/LERCANIDIPINE
  • STRONG & MOD 3A4 INHIB THAT PROLONG QT/CILOSTAZOL (> 50 MG)
  • STRONG CYP3A4 INHIBITORS/DAPAGLIFLOZIN-SAXAGLIPTIN-METFORMIN
  • STRONG AND MODERATE CYP3A4 INHIBITORS/ASUNAPREVIR
  • STRONG OR MODERATE CYP3A4 INHIBITORS/LOMITAPIDE
  • SELECTED STRONG CYP3A4 INHIBITORS/ISAVUCONAZONIUM
  • STRONG CYP3A4 INHIBITORS/NALOXEGOL
  • STRONG CYP3A4 INHIBITORS/AVANAFIL
  • 3A4INHIB/DAPOXETINE;LEVOMILNACIPRAN(>80MG);VILAZODONE(>20MG)
  • STRONG OR MODERATE CYP3A4 INHIBITORS/FLIBANSERIN
  • STRONG CYP3A4 INHIBITORS/SLT HIGH STRENGTH ANTIMUSCARINICS
  • SELECTED STRONG CYP3A4 INHIBITORS/DOMPERIDONE; CISAPRIDE
  • STRONG CYP3A4 INHIBITORS; PROTEASE INHIBITORS/TICAGRELOR
  • SELECTED AZOLE ANTIFUNGAL AGENTS/LURASIDONE
  • STRONG CYP3A4 INHIB;ATAZANAV;DARUNAVIR/SAXAGLIPTIN (>2.5 MG)
  • STRONG CYP3A4 INHIBITORS; ATAZANAVIR; DARUNAVIR/DRONEDARONE
  • POSACONAZOLE/SIROLIMUS
  • P-GP AND STRONG CYP3A4 INHIBITORS/RIVAROXABAN
  • POSACONAZOLE/HALOFANTRINE
  • STRONG CYP3A4 INHIBITORS/TOLVAPTAN
  • STRONG CYP3A4 INHIBITORS/SILODOSIN; TAMSULOSIN
  • STRONG CYP3A4 INHIBITORS/EPLERENONE
  • STRONG CYP3A4 INHIBITORS/IRINOTECAN
  • POSACONAZOLE; VORICONAZOLE/ERGOT ALKALOIDS
  • SELECTED AZOLE ANTIFUNGALS/ELETRIPTAN
  • SELECTED AZOLE ANTIFUNGALS/DISOPYRAMIDE; QUINIDINE
  • SELECTED AZOLE ANTIFUNGALS/PIMOZIDE
  • STRONG CYP3A4 INHIBITORS/VARDENAFIL (>2.5 MG)
  • Serious Interactions

    These medications may interact and cause very harmful effects. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.

  • POSACONAZOLE/RIFAMYCINS
  • POSACONAZOLE/SELECTED ANTICONVULSANTS
  • ITRACONAZOLE; KETOCONAZOLE; POSACONAZOLE/EFAVIRENZ
  • POSACONAZOLE; VORICONAZOLE/TACROLIMUS
  • STRONG CYP3A4 INHIBITORS/MITAPIVAT
  • STR 3A4 INHIB PROL QT/TOLTERODINE (>1 MG IR OR >2 MG ER)
  • STRONG CYP3A4 INHIBITORS/RIVOCERANIB
  • STRONG CYP3A4 INHIBITORS/DARIDOREXANT
  • STRONG CYP3A4 INHIBITORS/UPADACITINIB (>=30 MG)
  • STRONG CYP3A4 INHIBITORS/RUPATADINE
  • SELECT CYP3A4 INHIBITORS THAT PROLONG QT/TRAZODONE
  • STRONG & MODERATE 3A4 INHIB THAT PROLONG QT/ENCORAFENIB
  • STRONG CYP3A4 INHIBITORS/SURUFATINIB
  • STRONG CYP3A4 INHIBITORS/AVACOPAN
  • STRONG CYP3A4 INHIBITORS THAT PROLONG QT/RIBOCICLIB
  • STRONG 3A4 INHIBITORS THAT PROLONG QT/BEDAQUILINE;DELAMANID
  • STRONG & MODERATE 3A4 INHIBITOR THAT PROLONG QT/FEXINIDAZOLE
  • MYELOSUPPRESSIVES; IMMUNOMODULATORS/SODIUM IODIDE I 131
  • STRONG AND MODERATE CYP3A4 INHIBITORS/INFIGRATINIB
  • STRONG CYP3A4 INHIBITORS THAT PROLONG QT/GLASDEGIB
  • DUAL STRONG CYP3A4 INHIBITOR & P-GP INHIBITORS/TEPOTINIB
  • STRONG CYP3A4 INHIBITORS THAT PROLONG QT/TOREMIFENE
  • STRONG CYP3A4 INHIBITORS THAT PROLONG QT/SUNITINIB
  • STRONG CYP3A4 INHIBITORS THAT PROLONG QT/PAZOPANIB
  • STRONG CYP3A4 INHIBITORS THAT PROLONG QT/NILOTINIB
  • STRONG CYP3A4 INHIBITORS THAT PROLONG QT/LAPATINIB
  • STRONG CYP3A4 INHIBITORS THAT PROLONG QT/DASATINIB
  • STRONG CYP3A4 INHIBITORS THAT PROLONG QT/CRIZOTINIB
  • STRONG CYP3A4 INHIBITORS THAT PROLONG QT/CERITINIB
  • STRONG CYP3A4 INHIBITORS THAT PROLONG QT/BOSUTINIB
  • STRONG CYP3A4 INHIBITORS/VINFLUNINE
  • STRONG CYP3A4 INHIBITORS/VINCRISTINE
  • STRONG CYP3A4 INHIBITORS/VINBLASTINE
  • STRONG CYP3A4 INHIBITORS/TOFACITINIB
  • STRONG CYP3A4 INHIBITORS/SONIDEGIB
  • STRONG CYP3A4 INHIBITORS/RUXOLITINIB
  • STRONG CYP3A4 INHIBITORS/PONATINIB
  • STRONG CYP3A4 INHIBITORS/PALBOCICLIB
  • STRONG CYP3A4 INHIBITORS/PACLITAXEL
  • STRONG CYP3A4 INHIBITORS/OLAPARIB
  • STRONG CYP3A4 INHIBITORS/IXABEPILONE
  • STRONG CYP3A4 INHIBITORS/IDELALISIB
  • STRONG CYP3A4 INHIBITORS/ERLOTINIB
  • STRONG CYP3A4 INHIBITORS/DOXORUBICIN
  • STRONG CYP3A4 INHIBITORS/DOCETAXEL
  • STRONG CYP3A4 INHIBITORS/DABRAFENIB
  • STRONG CYP3A4 INHIBITORS/COBIMETINIB
  • STRONG CYP3A4 INHIBITORS/CABOZANTINIB
  • STRONG CYP3A4 INHIBITORS/CABAZITAXEL
  • STRONG CYP3A4 INHIBITORS/AXITINIB
  • STRONG CYP3A4 INHIBITORS/SUVOREXANT
  • STRONG CYP3A4 INHIBITORS THAT PROLONG QT/IVOSIDENIB
  • STRONG CYP3A4 AND P-GP INHIBITORS/PRALSETINIB
  • STRONG CYP3A4 INHIBITORS/PLITIDEPSIN
  • STRONG CYP3A4 INHIBITORS THAT PROLONG QT/VEMURAFENIB
  • KETOCONAZOLE; POSACONAZOLE/ATORVASTATIN
  • STRONG AND MODERATE CYP3A4 INHIBITORS/LURBINECTEDIN
  • STRONG CYP3A4 INHIBITORS THAT PROLONG QT/QUETIAPINE
  • STRONG CYP3A4 INHIBITORS THAT PROLONG QT/SELPERCATINIB
  • STRONG AND MODERATE CYP3A4 INHIBITORS/PEMIGATINIB
  • STRONG AND MODERATE CYP3A4 INHIBITORS/SELUMETINIB
  • STRONG CYP3A4 INHIBITORS THAT PROLONG QT/OSILODROSTAT
  • STRONG CYP3A4 INHIBITORS/RIMEGEPANT
  • STRONG CYP3A4 INHIBITORS/NIMODIPINE
  • STRONG CYP3A4 INHIBITORS THAT PROLONG QT/ROMIDEPSIN
  • STRONG CYP3A4 INHIBITORS/TAZEMETOSTAT
  • STRONG CYP3A4 INHIBITORS/AVAPRITINIB
  • STRONG AND MODERATE CYP3A4 INHIBITORS/LEMBOREXANT
  • POSSIBLE QT PROLONGING AGENTS/HYDROXYCHLOROQUINE
  • STRONG CYP3A4 INHIBITORS/ELEXACAFTOR-TEZACAFTOR-IVACAFTOR
  • STRONG CYP3A4 INHIBITORS/NALDEMEDINE
  • STRONG CYP3A4 INHIBITORS/ISTRADEFYLLINE
  • STRONG & MOD CYP3A4 INHIBITOR THAT PROLONG QT/ORAL LEFAMULIN
  • STRONG CYP3A4 INHIBITORS THAT PROLONG QT/ENTRECTINIB
  • STRONG CYP3A4 INHIBITORS/FEDRATINIB
  • STRONG CYP3A4 INHIBITORS/PEXIDARTINIB
  • SELECTED STRONG CYP3A4 INHIBITORS/CLOPIDOGREL
  • STRONG CYP3A4 INHIBITORS/LAROTRECTINIB
  • STRONG CYP3A4 INHIBITORS/LORLATINIB
  • STRONG CYP3A4 INHIBITORS/DUVELISIB
  • STRONG CYP3A4 INHIBITORS/ELAGOLIX
  • STRONG CYP3A4 INHIBITORS/ARIPIPRAZOLE LAUROXIL SUBMICRONIZED
  • STRONG AND MODERATE CYP3A4 INHIBITORS/TEZACAFTOR-IVACAFTOR
  • POSACONAZOLE; VORICONAZOLE/IBRUTINIB
  • STRONG CYP3A4 INHIBITORS/ACALABRUTINIB
  • STRONG CYP3A4 INHIBITORS/ABEMACICLIB
  • STRONG CYP3A4 INHIBITORS/COPANLISIB
  • STRONG CYP3A4 INHIB;MODERATE 3A4 & P-GP DUAL INHIB/NERATINIB
  • STRONG CYP3A4 INHIBITORS/BRIGATINIB
  • STRONG CYP3A4 INHIBITORS/VALBENAZINE
  • STRONG AND MODERATE CYP3A4 INHIBITORS/DEFLAZACORT
  • SLT STRONG 3A4 INHIBITORS/SILDENAFIL(PAH);TADALAFIL(BPH,PAH)
  • STRONG CYP3A4 INHIBITORS/VENETOCLAX
  • STRONG CYP3A4 INHIBITORS/TRABECTEDIN
  • STRONG CYP3A4 INHIBITORS/CARIPRAZINE
  • SLT STRONG CYP3A4 INHIBITOR & SUBSTRATE/LUMACAFTOR-IVACAFTOR
  • STRONG CYP3A4 INHIBITORS/TRASTUZUMAB EMTANSINE
  • STRONG 3A4 INHIBITORS/ESZOPICLONE > 2 MG; ZOPICLONE > 5 MG
  • STRONG CYP3A4 INHIBITORS/DACLATASVIR
  • STRONG & MODERATE CYP3A4 INHIBITORS/ELIGLUSTAT
  • STRONG CYP3A4 INHIBITORS/VORAPAXAR
  • POSSIBLE QT PROLONGING AGENTS/ANAGRELIDE
  • STRONG & MODERATE CYP3A4 INHIBITORS/GUANFACINE
  • POSACONAZOLE; VORICONAZOLE/SELECTED IMMUNOSUPPRESSANTS
  • STRONG OR MODERATE CYP3A4 INHIBITORS/SIMEPREVIR
  • STRONG CYP3A4 INHIBITORS/MACITENTAN
  • DUAL STRONG CYP3A4 INHIBITOR & P-GP INHIBITORS/RIOCIGUAT
  • STRONG AND MODERATE CYP3A4 INHIBITORS/BOSENTAN
  • P-GP AND STRONG CYP3A4 INHIBITORS/APIXABAN
  • STRONG CYP3A4 INHIBITORS/REGORAFENIB
  • STRONG CYP3A4 INHIBITORS; AMPRENAVIR;ATAZANAVIR/MIFEPRISTONE
  • STRONG AND MODERATE CYP3A4 INHIBITORS/IVACAFTOR
  • STRONG CYP3A4 INHIBITORS/EVEROLIMUS
  • STRONG CYP3A4 INHIBITORS/MARAVIROC
  • SELECTED QT PROLONGING AGENTS/ZIPRASIDONE
  • POSSIBLE QT PROLONGING AGENTS/SERTINDOLE
  • POSSIBLE QT PROLONGING AGENTS/DROPERIDOL
  • POSSIBLE QT PROLONGING AGENTS/LEVOMETHADYL
  • POSSIBLE QT PROLONGING AGENTS/SPARFLOXACIN
  • STRONG CYP3A4 INHIBITORS; ATAZANAVIR/COLCHICINE
  • SELECTED CYP3A4 INHIBITORS/SELECTED OPIOIDS
  • SLT AZOLE ANTIFUNGAL; LEVOKETOCONAZ/SELECTED VINCA ALKALOIDS
  • Moderate Interactions

    These medications may cause some risk when taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.

  • AZOLE ANTIFUNGALS/SULFONYLUREAS
  • POSACONAZOLE/QT PROLONGING AGENTS
  • POSACONAZOLE/FOSAMPRENAVIR
  • SELECTED AZOLE ANTIFUNGALS/BOCEPREVIR; TELAPREVIR
  • STRONG CYP3A4 INHIBITORS THAT PROLONG QT/CLOZAPINE
  • STRONG CYP3A4 INHIBITORS/LUMATEPERONE (<=10.5 MG)
  • QT PROLONGING AGENTS/SAVOLITINIB
  • QT PROLONGING AGENTS/TRICLABENDAZOLE
  • STRONG CYP3A4 INHIBITORS THAT PROLONG QT/GILTERITINIB
  • STR 3A4 INHIBITORS THAT PROLONG QT/PANOBINOSTAT (<= 10 MG)
  • STR 3A4 INHIB THAT PROL QT/TOLTERODINE (<=1 MG OR <=2 MG ER)
  • STRONG CYP3A4 INHIBITORS/UPADACITINIB (<30 MG)
  • STRONG CYP3A4 INHIBITORS/ATOGEPANT
  • SELECTED POSSIBLE QT PROLONGING AGENTS/INTRAVENOUS LEFAMULIN
  • QT PROLONGING AGENTS/OZANIMOD
  • QT PROLONGING AGENTS/PONESIMOD
  • QT PROLONGING AGENTS/SIPONIMOD
  • STRONG CYP3A4 INHIBITORS THAT PROLONG QT/MIDOSTAURIN
  • STRONG CYP3A4 INHIBITORS/IBREXAFUNGERP
  • STRONG CYP3A4 INHIBIT THAT PROLONG QT/PIMAVANSERIN (<=10 MG)
  • QT PROLONGING AGENTS/GALANTAMINE
  • STRONG CYP3A4 INHIBITORS/REPAGLINIDE
  • POSSIBLE QT PROLONGING AGENTS/LEVOMEPROMAZINE
  • STRONG CYP2D6 OR CYP3A4 INHIBITORS/OLICERIDINE
  • STRONG CYP3A4 INHIBITORS/FOSTAMATINIB
  • POSSIBLE QT PROLONGING AGENTS/OXALIPLATIN
  • QT PROLONGING AGENTS/AMISULPRIDE
  • STRONG CYP3A4 INHIBITORS/CANNABIDIOL-TETRAHYDROCANNABINOL
  • SELECTED STRONG CYP3A4 INHIBITORS/MEFLOQUINE
  • STRONG CYP3A4 INHIBITORS/ZANUBRUTINIB
  • P-GP AND STRONG CYP3A4 INHIBITORS/DAROLUTAMIDE
  • STRONG CYP3A4 INHIBITORS THAT PROLONG QT/ILOPERIDONE
  • STRONG CYP3A4 INHIBITORS/BREXPIPRAZOLE
  • STRONG CYP3A4 INHIBITORS/CLONAZEPAM
  • SELECTED CYP3A4 INHIBITORS/BROMOCRIPTINE; CABERGOLINE
  • POSSIBLE QT PROLONGING AGENTS/LENVATINIB
  • STRONG 3A4 INHIB/LEVOMILNACIPRAN(<=80MG);VILAZODONE(<=20MG)
  • QT PROLONGING AGENTS/FINGOLIMOD
  • STRONG CYP3A4 INHIBITORS/VARDENAFIL (<=2.5 MG)
  • POSSIBLE QT PROLONGING AGENTS/GADOFOSVESET
  • QT PROLONGING AGENTS/CIPROFLOXACIN
  • POSSIBLE QT PROLONGING AGENTS/LOPINAVIR
  • STRONG CYP3A4 INHIB;ATAZANAV;DARUNAVIR/SAXAGLIPTIN(<=2.5 MG)
  • SELECTED AZOLE ANTIFUNGALS/SELECTED CALCIUM CHANNEL BLOCKERS
  • POSACONAZOLE/ATAZANAVIR; RITONAVIR
  • SLT AZOLE ANTIFUNGALS; LEVOKETOCONAZOLE/GEFITINIB; IMATINIB
  • CYP3A4; CYP2C8; P-GLYCOPROTEIN (P-GP) INHIBITORS/LOPERAMIDE
  • POSSIBLE QT PROLONGING AGENTS/THIORIDAZINE
  • SELECTED AZOLE ANTIFUNGAL AGENTS/SELECTED CORTICOSTEROIDS
  • STRONG CYP3A4 INHIBITORS/BUSPIRONE
  • SELECTED AZOLE ANTIFUNGALS; LEVOKETOCONAZOLE/BUSULFAN
  • STRONG CYP3A4 INHIBITORS/ESZOPICLONE; ZOPICLONE; ZOLPIDEM
  • STRONG CYP3A4 INHIBITORS/CINACALCET
  • STRONG CYP3A4 INHIBITORS; ATAZANAVIR; DARUNAVIR/ARIPIPRAZOLE
  • SELECTED AZOLE ANTIFUNGALS/FELODIPINE; NISOLDIPINE
  • STRONG CYP3A4 INHIBITORS/SLT LOW STRENGTH ANTIMUSCARINICS
  • POSACONAZOLE/SELECTED BENZODIAZEPINES
  • STRONG & MOD 3A4 INHIB THAT PROLONG QT/CILOSTAZOL (<=50MG)
  • SLT STRONG CYP3A4 INHIBITORS/SILDENAFIL (ED); TADALAFIL (ED)
  • Drug Survey

    Are you currently using Noxafil Vial?

    This survey is being conducted by the WebMD marketing sciences department.

    Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.

    CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.